Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinluosu + red yeast rice
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination involves Xinluosu, which is not explicitly defined in the provided context, and red yeast rice, a traditional Chinese dietary supplement known for its potential to lower cholesterol levels due to its content of monacolin K, a statin-like compound. Red yeast rice is used to improve cardiovascular health by reducing LDL cholesterol and has been associated with potential side effects similar to statins, such as liver damage and muscle pain.
- Other names
- 新络素 + 红曲
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on Xinluosu + red yeast rice.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinluosu + red yeast rice.